Success Stories: Premium Processing Delivers 13-Day EB1B Approval for Nutrition Assistant Professor

Client’s Testimonial:

“My experience with Chen Immigration Group for my I-140 application was exceptional. The entire process was clear, well-structured, and easy to follow. They responded to all my questions promptly (always within 24 hours) and with great detail. The preparation phase took about four months, and afterward my I-140 was approved in just 13 days through premium processing. Because my case and petition letter were presented so effectively, my I-485 application was also approved within about three months. I am deeply grateful to Chen Group for their outstanding representation and highly recommend their services to anyone considering applying for a Green Card. Thank you, Chen Group!”

On February 18^th, 2025, we received another EB-1B (Outstanding Professors and Researchers) approval for an Assistant Professor in the Field of Nutrition (Approval Notice).

General Field: Nutrition

Position at the Time of Case Filing: Assistant Professor

Country of Origin: Iran

State of Residence at the Time of Filing: Missouri

Approval Notice Date: February 18^th, 2025

Processing Time: 13 days (Premium Processing Requested)

Case Summary:

North America Immigration Law Group (NAILG) is pleased to announce the EB1B approval for a leading researcher in nutrition science whose work has reshaped how the medical community approaches metabolic disorders such as nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes. The client’s research uniquely integrates nutritional compounds and exercise strategies to target some of the most urgent public health concerns of our time.

Renowned for advancing innovative nutritional and exercise-based interventions, the client has developed novel therapeutic strategies that address the root causes of metabolic dysfunction and improve overall cellular health. This body of work spans multiple research areas, combining insights from nutritional biochemistry, disease prevention, and physical activity to create comprehensive, evidence-based approaches for enhancing metabolic well-being.

The scope of their influence is evident in an impressive academic portfolio:

29 peer-reviewed journal articles, with 9 as first author, 18 abstracts, including 9 first-authored.
1,028 citations according to Google Scholar, placing the client among the top 1% of authors in nutritional science over the last decade.
Over 20 peer reviews for respected scientific journals.
Research funding from the Saskatchewan Health Research Foundation reflects the trust and investment of prominent funding bodies.

Their work continues to be recognized globally, not only for its scientific merit but also for its capacity to inspire new directions in research. In the words of a distinguished expert in the field:

“As a highly prominent researcher in nutrition, [client] has demonstrated the protective advantages of dietary polyphenol treatments for mitochondrial health. When this is taken into consideration with his contribution to the development of mitochondrial-targeted therapies for NAFLD, it is clear that [client]’s work is of great value to the field and that he is an irreplaceable presence in the research sphere.”

With NAILG’s comprehensive case preparation and tailored presentation of evidence, USCIS recognized the client’s sustained international acclaim and outstanding contributions to the field. This EB1B approval not only affirms their distinguished standing but also paves the way for continued advancements in nutritional science and the development of life-changing therapies.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.